NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,894,137 | -0.4% | 67,682 | -1.3% | 0.31% | -0.3% |
Q2 2023 | $6,922,205 | +23.7% | 68,598 | +12.8% | 0.31% | +11.5% |
Q1 2023 | $5,595,112 | -8.6% | 60,816 | -9.8% | 0.28% | -18.4% |
Q4 2022 | $6,118,573 | +305.7% | 67,445 | +239.9% | 0.34% | +327.5% |
Q3 2022 | $1,508,000 | -13.2% | 19,842 | -3.5% | 0.08% | -26.6% |
Q2 2022 | $1,738,000 | +14.0% | 20,564 | +18.3% | 0.11% | +5.8% |
Q1 2022 | $1,525,000 | +69.4% | 17,382 | +69.0% | 0.10% | +83.9% |
Q4 2021 | $900,000 | +66.1% | 10,284 | +55.3% | 0.06% | +47.4% |
Q3 2021 | $542,000 | -40.8% | 6,622 | -34.0% | 0.04% | -42.4% |
Q2 2021 | $915,000 | +31.1% | 10,028 | +22.8% | 0.07% | +13.8% |
Q1 2021 | $698,000 | -4.6% | 8,167 | +5.4% | 0.06% | -17.1% |
Q4 2020 | $732,000 | +11.9% | 7,750 | +3.1% | 0.07% | -4.1% |
Q3 2020 | $654,000 | -36.8% | 7,518 | -36.5% | 0.07% | -45.1% |
Q2 2020 | $1,034,000 | +78.0% | 11,843 | +68.1% | 0.13% | +43.0% |
Q1 2020 | $581,000 | – | 7,046 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |